ArticleFrontiers in pharmacology2022

Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial.

Ximei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.